Ritter Pharmaceuticals, Inc. Names Matthew W. Foehr To Its Board Of Directors

Ritter Pharmaceuticals, Inc., a privately held pharmaceutical company focused on gastrointestinal disorders, announces the appointment of Matthew W. Foehr to the Company’s Board of Directors. Mr. Foehr is President and Chief Operating Officer of Ligand Pharmaceuticals (NASDAQ: LGND) and his appointment expands Ritter’s Board membership to five Directors.

Help employers find you! Check out all the jobs and post your resume.